Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Working Memory01:24

Working Memory

Working memory refers to a combination of components, including short-term memory and attention, that allow an individual to hold information temporarily as we perform cognitive tasks. It is an essential cognitive function that enables the execution of complex tasks such as problem-solving, comprehension, and reasoning. Unlike short-term memory, which simply involves the storage of information for a brief period, working memory involves the active manipulation and processing of this information.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of Alcohol Use Disorder Pharmacotherapies by Sex: Systematic Review and Meta-Analysis.

Drug and alcohol review·2026
Same author

The Socioeconomic Impact of Long-Acting Injectable Buprenorphine.

ClinicoEconomics and outcomes research : CEOR·2026
Same author

Everyday discrimination in individuals seeking treatment/receiving support for substance use and caregivers.

The International journal on drug policy·2026
Same author

The stigma of alcohol use during pregnancy: Exploring the impact of alcohol strength and social context on public perceptions.

PloS one·2026
Same author

A thematic analysis of flu vaccine hesitance in ethnically minoritised communities in Liverpool.

PloS one·2025
Same author

Investigating outcomes in a substance use treatment provider: a cross-sectional comparison of long-acting injectable buprenorphine and oral medication for opioid use disorder.

BMJ open·2025

Related Experiment Video

Updated: May 21, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

Visuospatial working memory impairment in current and previous ecstasy/polydrug users.

John E Fisk1, Catharine Montgomery, Florentia Hadjiefthyvoulou

  • 1Department of Psychology, University of Central Lancashire, Preston, UK. jfisk@uclan.ac.uk

Human Psychopharmacology
|June 16, 2012
PubMed
Summary

Ecstasy users show deficits in visuospatial working memory (VSWM), particularly with complex tasks. This impairment persists even after accounting for other drug use, suggesting a specific effect of ecstasy.

More Related Videos

Assessment of Memory Function in Pilocarpine-induced Epileptic Mice
13:34

Assessment of Memory Function in Pilocarpine-induced Epileptic Mice

Published on: June 4, 2020

Assessing Human Spatial Navigation in a Virtual Space and its Sensitivity to Exercise
06:17

Assessing Human Spatial Navigation in a Virtual Space and its Sensitivity to Exercise

Published on: January 26, 2024

Related Experiment Videos

Last Updated: May 21, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
07:30

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

Assessment of Memory Function in Pilocarpine-induced Epileptic Mice
13:34

Assessment of Memory Function in Pilocarpine-induced Epileptic Mice

Published on: June 4, 2020

Assessing Human Spatial Navigation in a Virtual Space and its Sensitivity to Exercise
06:17

Assessing Human Spatial Navigation in a Virtual Space and its Sensitivity to Exercise

Published on: January 26, 2024

Area of Science:

  • Neuroscience
  • Psychology

Background:

  • Previous studies indicate ecstasy users have visuospatial processing deficits.
  • Observed impairments often relate to recalling complex visual and geometric patterns.

Purpose of the Study:

  • To investigate if ecstasy use is linked to deficits in serial spatial recall and visuospatial working memory (VSWM).

Main Methods:

  • 38 current ecstasy/polydrug users, 16 past users, and 52 non-users completed serial simple spatial recall and VSWM tasks.

Main Results:

  • Both current and previous ecstasy users demonstrated VSWM task deficits.
  • After controlling for cannabis and cocaine use, the overall group effect was marginally significant.
  • A significant ecstasy-related VSWM deficit was evident when comparing users directly with non-users.

Conclusions:

  • Ecstasy users exhibit visuospatial processing impairments, especially under high cognitive load.
  • Findings suggest potential ecstasy-related dysfunction in posterior parietal/occipital areas or dorsolateral prefrontal cortex.
  • Further research is required to identify the precise origin of these observed VSWM deficits.